Access cutting-edge fabry disease treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.
Access fabry disease specialists in Chicago at no cost
This study follows strict safety protocols and ethical guidelines
All study-related fabry disease treatment provided free
The main goals of this clinical study are to characterize safety and PK/PD of AMT-191 i.e. if drug doses used in the study are safe and tolerable and to understand how it acts in the body of people with Fabry disease.
Sponsor: UniQure Biopharma B.V.
Check if you qualify for this fabry disease clinical trial in Chicago, IL
If you're searching for fabry disease treatment options in Chicago, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced fabry disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.